Key facts
- It has raised $3.0M across 1 recorded rounds; the latest was Seed Round ($2.0M) in Nov 2025.
- Notable investors include Invest Nova Scotia, Atlantic Canada Opportunities Agency, Life Sciences Nova Scotia.
- ClearDynamic has filed 1 Form D with the SEC, most recently Dec 2025 ($2.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for ClearDynamic
Funding rounds
1 roundsAbout ClearDynamic
Developer of a microscopic glass microsphere platform designed to provide safe, long-term, drug-free relief from joint pain. The company's platform uses microscopic glass microspheres that are injected into the bloodstream and carried to the site of joint pain from osteoarthritis and are intended to block the pain receptors, reduce pain, and dissolve completely after treatment, enabling patients to have a drug-free alternative to pain medication.
- Sector
- Healthcare
- HQ
- Halifax, Canada
- Founded
- 2022
- Employees
- 22
- Website
- cleardynamic.com/
- Ownership
- Privately Held (backing)
ClearDynamic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ClearDynamic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ClearDynamic in its N-PORT filings yet. We sweep new filings monthly.